The administration of intravenous human albumin has been utilized in cirrhosis patients in various settings, such as after large-volume paracentesis, in the long-term management of decompensation and in spontaneous bacterial peritonitis [9,10]. The gene discussed is ALB; the disease is Cirrhosis.